Ensysce Biosciences Inc (ENSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 828 | 1,825 | 0 | 0 | 0 |
| Gross Profit | 828 | 1,825 | N/A | N/A | N/A |
| Operating Expenses | 1,232 | 1,686 | 915 | 1,929 | 584 |
| Operating Income | -405 | 139 | -915 | -1,929 | -584 |
| Interest Expense | 216 | 202 | 31 | 0 | 0 |
| Other Income | 2,172 | -644 | 2,814 | -723 | 1,088 |
| Pre-tax Income | 1,551 | -707 | 1,867 | -2,653 | 504 |
| Income Tax | N/A | N/A | 75 | 99 | 14 |
| Net Income Continuous | 1,551 | -707 | 1,793 | -2,752 | 490 |
| Minority Interests | -20 | -2 | N/A | N/A | N/A |
| Net Income | $1,571 | $-705 | $1,793 | $-2,752 | $490 |
| EPS Basic Total Ops | 359.96 | -143.99 | 1,007.90 | -1,511.85 | -287.97 |
| EPS Basic Continuous Ops | 353.94 | -161.27 | 1,012.26 | -1,632.49 | 288.99 |
| EPS Diluted Total Ops | 323.97 | -143.99 | 1,007.90 | -1,511.85 | -287.97 |
| EPS Diluted Continuous Ops | 331.25 | -161.27 | 1,012.26 | -1,632.49 | 288.99 |
| EBITDA(a) | $-405 | $108 | $-884 | $-1,929 | $-584 |